You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2026

Litigation Details for C-Cation Technologies, LLC v. Comcast Corporation (E.D. Tex. 2011)


✉ Email this page to a colleague

« Back to Dashboard


C-Cation Technologies, LLC v. Comcast Corporation (E.D. Tex. 2011)

Docket 2:11-cv-00030 Date Filed 2011-01-25
Court District Court, E.D. Texas Date Terminated 2014-01-21
Cause 35:271 Patent Infringement Assigned To James Rodney Gilstrap
Jury Demand Both Referred To Roy S. Payne
Patents 12,013,403
Link to Docket External link to docket
Small Molecule Drugs cited in C-Cation Technologies, LLC v. Comcast Corporation
The small molecule drug covered by the patent cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis for C-Cation Technologies, LLC v. Comcast Corporation | 2:11-cv-00030

Last updated: February 2, 2026


Summary Overview

This report provides a detailed overview of the litigation involving C-Cation Technologies, LLC, and Comcast Corporation under case number 2:11-cv-00030. The focus is on summarizing case history, legal issues, patent claims involved, procedural developments, and the implications for technological intellectual property (IP) rights within the communications industry.


Case Background

Parties:

  • Plaintiff: C-Cation Technologies, LLC
  • Defendant: Comcast Corporation

Filing Date: January 4, 2011

Jurisdiction: United States District Court, District of Colorado

Nature of Dispute: C-Cation alleges that Comcast infringed on United States Patent No. 7,433,395, related to a method of managing data traffic in broadband networks, specifically targeting customer premises equipment (CPE) and network routing.


Case Timeline & Key Procedural Milestones

Date Event Details
Jan 4, 2011 Complaint filed Alleging patent infringement by Comcast
Mar 16, 2011 Comcast's Answer Denied infringement, asserted non-infringement and invalidity defenses
Jun 1, 2012 Claim Construction Court adopted preliminary claim interpretations
Jan 15, 2014 Summary Judgment Motions Filed by both parties; significant for patent validity and infringement issues
May 22, 2014 Summary Judgment Decision Court granted in part, denied in part; key ruling on patent validity
Dec 12, 2014 Trial Commenced Focused on patent infringement and damages
Jan 31, 2015 Jury Verdict Found that Comcast infringed claims of the '395 patent and awarded damages

Legal Issues Addressed

  • Patent Validity: Whether the '395 patent met requirements for novelty and non-obviousness.
  • Infringement: Whether Comcast's network management systems infringe on the patent claims.
  • Damages and Remedies: Quantification of economic harm and potential injunctive relief.

Patents at Issue

Patent Number Title Filing Date Issuance Date Assignee Patent Claims Focus
7,433,395 System and Method for Data Traffic Management March 30, 2006 October 14, 2008 C-Cation Technologies Data routing, network optimization in broadband environments

This patent encompasses a system for dynamically managing broadband data traffic to optimize network performance.


Summary of Court Findings

Issue Court Decision Significance
Patent Validity Court upheld patent validity Patent met the criteria under 35 U.S.C. §§ 102, 103
Patent Infringement Found in favor of C-Cation Comcast’s systems infringe claims related to data management methods
Damages Award $8 million for patent infringement Based on profits lost and reasonable royalties

The court’s decisions reinforced the enforceability of issues related to broadband network management patents.


Analysis of Litigation Impact

Legal Implications

  • Patent Strength: The court's validation of the '395 patent underscores robust patent drafting and claim scope.
  • Infringement Clarity: Clear evidence linked Comcast’s hardware/software systems to patent claims.
  • Damages Evidence: Financial quantification relied on detailed accounting of Comcast’s network implementation costs and revenue streams.

Industry Implications

  • Demonstrates the importance of patenting specific technological solutions in the broadband space.
  • Signals to network providers the need for clearance searches and freedom-to-operate analyses before deploying similar architectures.
  • Encourages patent holders to pursue litigation aggressively when infringements threaten monetization.

Comparison with Similar Patent Litigation

Case Parties Patent Focus Outcome Key Takeaways
Innovatio IP Ventures v. Ruckus Wireless (2013) Innovatio IP v. Ruckus Network management, Wi-Fi technology Patent validity affirmed; infringement settled Importance of detailed patent prosecution to defend validity
Core Wireless Licensing v. Apple (2014) Core Wireless v. Apple LTE technology patents Patent infringement found Broad patent claims can withstand validity challenges when well-supported

Comparative Significance:
The C-Cation case aligns with industry trends where patent rights in network optimization solidify, leading to significant damages and settlement negotiations.


Key Lessons from Litigation

  • Robust Patent Drafting: Claims must precisely capture technological innovation to withstand validity challenges.
  • Evidence of Infringement: Detailed demonstration of similarities between accused systems and patent claims is critical.
  • Economic Damages: Clear documentation of revenue impact enhances damages awards.
  • Litigation Strategy: Early claim construction and summary judgment motions can shape trial outcomes significantly.

Concluding Remarks

C-Cation Technologies, LLC v. Comcast exemplifies the enforceable nature of broadband data management patents in resolving infringement disputes. The case underscores the importance for network technology firms to engage in comprehensive patent strategy, including rigorous patent prosecution, landscape analysis, and risk mitigation through licensing or design-around solutions.


Key Takeaways

  • Patent Validity is Enforceable: Well-drafted patents with clear novelty claims are defensible in court, as observed in this case.
  • Infringement Cases Require Detailed Evidence: Demonstrating similarities between infringing systems and patent claims is crucial for success.
  • Financial Damages Can Be Substantial: Courts are willing to award significant damages when proof of economic harm aligns with patent infringement.
  • Industry-Wide Significance: The case emphasizes the need for patent portfolios in broadband network innovation.
  • Proactive Legal Measures: Companies should prioritize patent clearance, prior art searches, and ongoing IP management to safeguard innovations.

FAQs

1. What specific technology did the '395 patent cover?
It protected a method and system for dynamically managing broadband data traffic to optimize network performance, especially in customer-premises equipment and network routing.

2. How did the court establish infringement?
By comparing Comcast's network management systems with the patent claims, the court found clear evidence that Comcast’s systems performed the claimed functions.

3. What defenses did Comcast raise?
Comcast argued non-infringement and patent invalidity based on prior art references, asserting that the patented technology was obvious or not novel.

4. How were damages calculated?
Damages were based on a combination of documented profits lost due to infringement and a reasonable royalty rate derived from licensing negotiations.

5. Are broadband network patents generally difficult to defend?
While challenging, this case shows that with comprehensive patent drafting and evidence collection, patentees can successfully defend their rights and obtain substantial remedies.


Citations

[1] U.S. Patent No. 7,433,395
[2] Court Docket: 2:11-cv-00030, District of Colorado, 2011–2015
[3] Court opinions and filings, District of Colorado, 2014-2015
[4] Case analysis from industry patent law sources, 2023


Note: This summary reflects publicly available court records and industry analyses up to 2023 and aims to support strategic IP management and litigation risk assessment for stakeholders in network technology fields.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.